Rubella Diagnostic Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Rubella Diagnostic Testing Market is Segmented by Testing Technique (Latex Agglutination, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA), Fluorescent Immunoassay (FIA), and Other Testing Techniques), Application, and Geography.

Market Snapshot

rubella diagnostic testing market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors for the growth of the rubella diagnostic testing market include the government initiatives to curb the rubella virus, increasing incidences of rubella, and the introduction of advanced point-of-care diagnostic technologies, which are expected to boost the overall growth of the market over the forecast period.

There has been an increase in the number of incidences of rubella across the world. Rubella is an acute, contagious viral infection that causes a mild fever and rash illness in children and adults. Infection during pregnancy, especially during the first trimester, can result in miscarriage, stillbirth, fetal death, or infants with congenital malformations. According to the data published by the Centers for Disease Control and Prevention (CDC), rubella is a global health concern, and every year, more than 100,000 cases of congenital rubella syndrome (CRS) are reported, globally. A woman infected with rubella during the first three months of pregnancy has up to a 90% of chance of giving birth to a baby with congenital rubella syndrome.

On the other hand, as per the Global Vaccine Action Plan (GVAP) Assessment report, rubella control is lagging, with 42 countries yet to introduced the vaccine.

Scope of the Report

As per the scope of the report, rubella diagnostic testing refers to the detection of the rubella virus. These tests are prescribed for pregnant women and may also be performed on babies born with congenital defects. Rubella can be detected with the help of various diagnostic tests, such as latex agglutination, enzyme immunoassay, radioimmunoassay (RIA), and fluorescent immunoassay (FIA), among others. Rubella Diagnostics Market is segmented By Testing Technique, By Application and Geography.

Testing Technique
Latex Agglutination
Enzyme Immunoassay (EIA)
Radioimmunoassay (RIA)
Fluorescent Immunoassay (FIA)
Other Testing Techniques
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Enzyme Immunoassay Segment under Testing Technique Accounted for the Largest Share in the Global Market

  • The detection of rubella-specific immunoglobulin M (IgM) in serum is the standard test for the rapid laboratory diagnosis of rubella. 
  • IgM testing is the most commonly performed testing technique using commercial enzyme immunoassay (EIA) kits. The blood test detects antibodies that are made by the immune system to kill the rubella virus, and these antibodies remain in the bloodstream for years. 
  • The segment is expected to account for the largest market share, owing to the rising incidences of rubella.
Rubella Diagnostics Market Trend.png

Asia-Pacific Accounted for the Highest Growth Rate in the Global Market

The Asia-Pacific segment, by geography, was found to register the fastest growth rate for the rubella diagnostic testing market, and is expected to show a similar trend over the forecast period, without significant fluctuations. 

The Asia-Pacific region holds the highest market share, owing to the presence of larger untapped opportunities, a lack of awareness in some countries, and government initiatives to curb the disease incidence. 

As per the Global Vaccine Action Plan (GVAP) Assessment report 2017, 42 countries have not yet introduced the vaccine, and two regions, Africa and the Eastern Mediterranean, have not yet set rubella elimination or control targets. Such regions are expected to face high incidences of rubella, which may further drive the growth of the market.

Rubella Diagnostic Testing Market - Growth Rate by Region

Competitive Landscape

The market studied is dominated by a few major players and most of the players present in the market are focusing on the development of new technologies to acquire the maximum market share. The presence of major market players, such as Abbott Laboratories, Bio Rad Laboratories Inc., BioMerieux SA, Siemens AG, and Thermo Fisher Scientific Inc., is increasing the overall competitive rivalry in the market.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Government Initiatives to Curb Rubella Virus

      2. 4.2.2 Increasing Incidences of Rubella

      3. 4.2.3 Introduction of Advance Point-of-care Diagnostic Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness among Developing Regions

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Testing Technique

      1. 5.1.1 Latex Agglutination

      2. 5.1.2 Enzyme Immunoassay (EIA)

      3. 5.1.3 Radioimmunoassay (RIA)

      4. 5.1.4 Fluorescent Immunoassay (FIA)

      5. 5.1.5 Other Testing Techniques

    2. 5.2 Application

      1. 5.2.1 Hospitals

      2. 5.2.2 Laboratories

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Beckman Coulter Inc.

      3. 6.1.3 Bio Rad Laboratories Inc.

      4. 6.1.4 Biokit SA

      5. 6.1.5 bioMérieux SA

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 Ortho Clinical Diagnostics

      8. 6.1.8 Siemens Healthcare GmbH

      9. 6.1.9 Thermo Fisher Scientific

      10. 6.1.10 ZEUS Scientific Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Rubella Diagnostic Testing Market market is studied from 2018 - 2026.

The Rubella Diagnostic Testing Market is growing at a CAGR of 4.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott, Bio Rad Laboratories Inc., bioMérieux SA, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc. are the major companies operating in Rubella Diagnostic Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!